VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection

Richard Rupp, Susan L Rosenthal, Lawrence R Stanberry, Richard Rupp, Susan L Rosenthal, Lawrence R Stanberry

Abstract

Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no commercial product is yet available, many candidates are under development. A leading candidate, VivaGel (SPL7013 Gel) is the product of nanotechnology. The active ingredient is SPL7013, a dendrimer that was designed specifically with HIV and HSV antiviral activity and human safety in mind. SPL7013 has demonstrated efficacy against human immunodeficiency virus and herpes simplex virus in in vitro and animal models. VivaGel appears to be well tolerated in both animals and humans. This review summarizes the studies of VivaGel and its active ingredient, SPL7013.

References

    1. Abner SR, Guenthner PC, Guarner J, et al. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. JID. 2005;192:1545–56.
    1. Bernstein DI, Stanberry LR, Sacks S, et al. Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob Agents Chemother. 2003;47:3784–8.
    1. Dezzutti CS, James VN, Ramos A, et al. In vitro comparison of topical microbicides for prevention of Human Immunodeficiency Virus type 1 transmission. Antimicrob Agents Chemother. 2004;48:3834–44.
    1. Gong E, Matthews B, McCarthy T, et al. Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antivir Res. 2005;68:139–46.
    1. Jiang YH, Emau P, Cairns JS, et al. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV 89.6P in Macaques. AIDS Res Hum Retrovir. 2005;21:207–13.
    1. McCarthy TD, Karellas P, Henderson SA, et al. Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention. Mol Pharm. 2005;2:312–18.
    1. Patton DL, Sweeney YT, McCarthy TD, et al. Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother. 2006;50:1696–700.
    1. Starpharma 2006aVivagel fast track status [online]. Accessed 18 Aug 2006. URL:
    1. Starpharma. Vivagel is a potent contraceptive in animal model [online] 2006b. Accessed 18 Aug 2006. URL: .
    1. Starpharma. Vivagel IND for genital herpes trial clears FDA [online] 2006c. Accessed 18 Aug 2006. URL: .
    1. Turpin JA. Considerations and development of topical microbicides to inhibit sexual transmission of HIV. Expert Opin Investig Drugs. 2002;11:1077–97.
    1. UNAIDS. Report on the global AIDS epidemic: May 2006 [online] 2006. URL: .

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner